Zusammenfassung
Die Zukunft technischer Entwicklungen vorhersagen zu wollen ist immer auf einer subjektiven Einschätzung begründet und daher naturgemäß schwierig. Um die Zukunft der Bildgebung abschätzen zu können, wird jeweils die aktuelle Situation beleuchtet und davon ausgehend mögliche Entwicklungen dargestellt. Dabei ist ein zentraler Punkt die heute mithilfe von Computersystemen erhobene umfangreiche Menge von Patientendaten, die mit bestehenden Techniken neu verknüpft werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Literatur zu Abschn. 10.1
AWMF (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, herapie und Nachsorge des Mammakarzinoms. AWMF-Register Nr. 032-045 OL
Baltzer P A T, Yang F, Dietzel M, Herzog A, Simon A, Vag T et al (2010) Sensitivity and specificity of unilateral edema on T2w-TSE sequences in MR-Mammography considering 974 histologically verified lesions. Breast J 16(3):233–239
Boyd D, (2015) Privacy and Publicity in the Context of Big Data [Online] Verfügbar unter: http://www.danah.org/papers/talks/2010/WWW2010.html [Zugegriffen: 30-Dez-2015]
Dietzel M, Baltzer P A T, Vag T, Gröschel T, Gajda M, Camara O, Kaiser W A (2010) Application of breast MRI for prediction of lymph node metastases – systematic approach using 17 individual descriptors and a dedicated decision tree. Acta Radiol 51(8):885-894
Dietzel M, Baltzer P A, Vag T, Zoubi R, Gröschel T, Burmeister H, Gajda M et al (2011) Potential of MR mammography to predict tumor grading of invasive breast cancer. RoFo 183( 9):826–833
Eccles S A, Aboagye E O, Ali S, Anderson A S, Armes J, et al (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer, Breast Cancer Res BCR, 15(5)R92
Guestini F, McNamara K M, Ishida T, Sasano H (2015) Triple Negative Breast Cancer Chemosensitivity and Chemoresistance: Current Advances in Biomarkers Indentification, Expert Opin Ther Targets
Hood L, Friend S H (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8(3):184–187
Leskovec J, Rajaraman A, Ullman J D (2014) Mining of Massive Datasets, 2 Aufl Cambridge, Cambridge University Press
Nienhuis H H, Gaykema S B M, Timmer-Bosscha H, Jalving M, Brouwers A H et al (2015) Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets. Pharmacol Ther 147:63–79
Pinker K, Helbich T, Magometschnigg H, Fueger B, Baltzer P (2014) Molecular breast imaging : An update. Radiol 54(3):241–253
Literatur zu Abschn. 10.2
Baselga J et al (2015) PIK3CA Status in Circulating Tumor DNA Predicts Efficacy of Buparlisib Plus Fulvestrant in Postmenopausal Women With Endocrine-resistant HR+/HER2– Advanced Breast Cancer: First Results From the Randomized, Phase III BELLE-2 Trial. San Antonio Breast Cancer Symposium SS 6–01
Bundesministerium für Bildung und Forschung (2015) Begleitende Evaluierung des Förderinstruments »Spitzencluster-Wettbewerb« des BMBF. http://www.rwi-essen.de/media/content/pages/publikationen/rwi-projektberichte/RWI-PB_Spitzencluster.pdf
Bundesministerium für Wirtschaft und Energie (2014) »Smart Data« – Projekte des neuen BMWi-Technologieprogramms sind ausgewählt, http://www.bmwi.de/DE/Presse/pressemitteilungen,did=642872.html
Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70
Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609–615
Cancer Genome Atlas Research Network et al (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67–73
Cheang MC et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101(10):736–750
Cortazar P et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384(9938):164–172
Couch FJ et al (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33(4):304–311
Fasching PA et al (2012) The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 21(17):3926–3939
Fasching PA et al (2013) Breast Cancer Risk – From Genetics to Molecular Understanding of Pathogenesis. Geburtshilfe Frauenheilkd 73(12):1228–1235
Google Inc. (2012) Introducing the Knowledge Graph: things, not strings. http://googleblog.blogspot.com/2012/05/introducing-knowledge-graph-things-not.html
Google Inc. (2015) A remedy for your health-related questions: health info in the Knowledge Graph http://googleblog.blogspot.nl/2015/02/health-info-knowledge-graph.html
Häberle L et al (2012) Characterizing mammographic images by using generic texture features. Breast Cancer Res 14(2):R59
Häberle L et al (2016) Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography. Int J Cancer 139(9):1967–1974
Katzorke N et al (2013) Prognostic value of HER2 on breast cancer survival. J Clin Oncol 31 (suppl; abstr 640)
Kojima Y, Tsunoda H (2011) Mammography and ultrasound features of triple-negative breast cancer. Breast Cancer 18(3):146–151
Kojima Y et al (2011) Radiographic features for triple negative ductal carcinoma in situ of the breast. Breast Cancer 18(3):213–220
Lander ES et al (2001) Initial sequencing and analysis of the human genome. Nature 409(6822):860–921
Mavaddat N et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 107(5). pii: djv036. doi: 10.1093/jnci/djv036
Meier-Meitinger M et al (2012) Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients. Eur J Surg Oncol 44–51
Nolan E et al (2016) RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nat Med 22(8):933–939
Perou CM et al (2000) Molecular portraits of human breast tumours. Nature 747–52
Purrington KS et al (2014) Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 1012–9
Sigl V et al (2016) RANKL/RANK control Brca1 mutation-driven mammary tumors. Cell Res 761–74
Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 790–800
Vachon CM et al (2015) The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 107(5). pii: dju397. doi: 10.1093/jnci/dju397
Venter JC et al (2001) The sequence of the human genome. Science 1304–51
Yaghjyan L et al (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 1179–89
Literatur zu Abschn. 10.4
Anton G, Bayer F, Beckmann M W, Durst J, Fasching P A, Haas W et al (2013) Grating-based dark-field imaging of human breast tissue; ZMP 23, 228
Bech M, Jensen TH, Feidenhaus R, Bunk O, David C, Pfeiffer F (2009) Soft-tissue phase-contrast tomography with an x-ray tube source; Phys Med Biol 54:2747
David C, Nöhammer B, Solak H H, Ziegler E (2002) Differential x-ray phase contrast imaging using a shearing interferometer; Applied Physics Letters 81(17):3287–3289
Donath T, Pfeiffer F, Bunk O, Grünzweig C, Hempel E, Popescu S, Vock P, David C (2010) Toward clinical x-ray phase-contrast ct: demonstration of enhanced soft-tissue contrast in human specimen; Investigative radiology 45(7):445–452
Michel T, Rieger J, Anton G, Bayer F, Beckmann M W, Durst J et al (2013) On a dark-field signal generated by micrometer sized calcifications in phase-contrast mammography; Phys Med Biol 58:2713
Momose A, Kawamoto S, Koyama I, Hamaishi Y, Takai K, Suzuki Y (2003) Demonstration of x-ray talbot interferometry; Jpn J Appl Phys 42( 2;7B)L866–L868
Pelzer G, Zang A, Anton G, Bayer F, Horn F, Kraus FM et al (2014) Energy weighted x-ray dark-field imaging; Optics Express 22(20):24507–24515
Pfeiffer F, Bech M, Bunk O, Kraft P, Eikenberry E F, Bronnimann C, Grunzweig C, David C (2008) Hard-x-ray dark-field imaging using a grating interferometer; Nat Mater 7(2):134–137
Pfeiffer F, Bunk O, David C, Bech M, Le Duc G, Bravin A, Cloetens P (2007) Highresolution brain tumor visualization using three-dimensional x-ray phase contrast tomography; Physics in medicine and biology 52(23):6923
Pfeiffer F, Weitkamp T, Bunk O, David C (2006) Phase retrieval and differential phasecontrast imaging with low-brilliance x-ray sources; Nature Phys 2:258–261
Pinzer B, Cacquevel M, Modregger P, McDonald S, Bensadoun J, Thuering T, Aebischer P, Stampanoni M (2012) Imaging brain amyloid deposition using grating-based differential phase contrast tomography; Neuroimage 61:1336–1346
Reznikova E, Mohr J, Boerner M, Nazmov V, Jakobs P (2008) Soft X-ray lithography of high aspect ratio SU8 submicron structures; Microsystem Technologies 14(9):1683–1688
Schleede S, Meinel F G, Bech M, Herzen J, Achterhold K, Potdevin G et al (2012) Emphysema diagnosis using x-ray dark-field imaging at a laser-driven compact synchrotron light source; Proceedings of the National Academy of Sciences (PNAS) 109(44):17880–17885
Shinohara M, Yamashita T, Tawa H, Takeda M, Sasaki N, Takaya T et al (2008) Atherosclerotic plaque imaging using phase-contrast x-ray computed tomography; American Journal of Physiology-Heart and Circulatory Physiology 294(2):H1094–H1100
Stutman D, Beck T J, Carrino J A, Bingham C O (2011) Talbot phase-contrast x-ray imaging for the small joints of the hand; Phys Med Biol 56(17):5697
Takeda M, Yamashita T, Shinohara M, Sasaki N, Tawa H, Nakajima K, Momose A, Hirata K-J (2012) Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phaseontrast x-ray ct imaging; The international journal of cardiovascular imaging 28(5):1181– 1191
Weitkamp T, David C, Bunk O, Bruder J, Cloetens P, Pfeiffer F (2008) X-ray phase radiography and tomography of soft tissue using grating interferometry; Eur J Radiology 68S:S13–S17
Yaroshenko A, Meinel F G, Bech M, Tapfer A, Velroyen A, Schleede S et al (2013) Pulmonary emphysema diagnosis with a preclinical small-animal x-ray dark-field scatter-contrast scanner; Radiology 269:427–433
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Anton, G., Baltzer, P., Emons, J., Fasching, P., Schulz-Wendtland, R., Weismann, C. (2017). Zukünftige Entwicklungen in der Bildgebung. In: Duda, V., Schulz-Wendtland, R. (eds) Mammadiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54263-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-54263-7_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-54262-0
Online ISBN: 978-3-662-54263-7
eBook Packages: Medicine (German Language)